Company · CIK 0001099215 · SIC 8731 — Services-Commercial Physical & Biological Research
PROTALEX INC · PRTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2018 PForm 4 → | Mar 2, 4:05 pm EST | Arnold P Kling +1President, Director, 10% Owner | 18,557,805 | $1.20 | $22,269,366 | 41,133,892 | +82.2% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2018 SForm 4 → | Mar 15, 4:06 pm EDT | Arnold P Kling +1President, Director, 10% Owner | 166,667 | — | — | 166,667 | — | |
| Feb 28, 2018 SForm 4 → | Mar 2, 4:05 pm EST | Arnold P Kling +1President, Director, 10% Owner | 4,750,000 | — | — | 4,750,000 | — | |
| Feb 28, 2018 PForm 4 → | Mar 2, 4:05 pm EST | Marco M ElserDirector | 2,500,000 | $500,000.00 | $1,250,000,000,000 | 2,500,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 10:21 am EST | Marco M ElserDirector | 300,000 | — | — | 300,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 10:19 am EST | Kirk M WarshawChief Financial Officer | 300,000 | — | — | 300,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 10:19 am EST | Arnold P KlingPresident, Director, 10% Owner | 600,000 | — | — | 600,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 7, 12:51 pm EDT | Kirk M WarshawChief Financial Officer | 250,000 | — | — | 250,000 | — | late |